EPAM (EPAM) Form 4: CEO receives 4,112 RSUs vesting through 2029
Rhea-AI Filing Summary
Fejes Balazs, who is listed as CEO, President and a Director of EPAM Systems, acquired 4,112 shares via restricted stock units on 09/01/2025 at a reported price of $0. After the grant, he beneficially owns 24,752 shares of EPAM common stock. The restricted stock units vest in four equal installments: 25% on each September 1 of 2026, 2027, 2028 and 2029. The Form 4 was executed on behalf of the reporting person by an attorney-in-fact, Kate Pytlewski, on 09/02/2025. No derivative transactions are reported on this form.
Positive
- Time‑based vesting aligns executive incentives with long‑term shareholder value through 2029
- Post‑transaction ownership of 24,752 shares increases the executive's stake in EPAM
Negative
- None.
Insights
TL;DR: Executive received time‑based equity that aligns incentives over four years, typical for retention and alignment.
The grant of 4,112 restricted stock units at $0 indicates a compensation award rather than an open‑market purchase. Vesting in four equal annual tranches ties the executive to the company through 2029, supporting retention and long‑term alignment with shareholders. The post‑transaction beneficial ownership of 24,752 shares provides a meaningful personal stake, though its materiality depends on total outstanding shares (not provided). Filing by an attorney‑in‑fact is routine and does not indicate a substantive change to ownership reporting.
TL;DR: This Form 4 reports a standard RSU grant; no sales or derivative exercises were disclosed.
The reported transaction code 'A' and price of $0 are consistent with a grant of restricted stock units rather than a market purchase. There are no disposals or option exercises recorded. The schedule of vesting (25% annually) is explicit, allowing investors to project potential increases in free‑floating shares as vesting dates pass. Absent additional context (total holdings, dilution impact), this is a routine insider compensation disclosure.